MTI
GILD icon

Merrithew & Thorsten Inc’s Gilead Sciences GILD Stock Holding History

Merrithew & Thorsten Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6K Hold
51
– – 0.01% 84
2026
Q1 		$7K Hold
51
– – 0.01% 82
2025
Q4 		$6K Buy
+51
New +$6.2K 0.01% 83

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Merrithew & Thorsten Inc's GILD Position: Q2 2026 in Review

Merrithew & Thorsten Inc held its Gilead Sciences (GILD) position steady in Q2 2026 at 51 shares worth $6K. The position accounts for 0.01% of the portfolio, ranked #84.

Merrithew & Thorsten Inc first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $7K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Merrithew & Thorsten Inc held 51 shares of Gilead Sciences worth $6K as of Q2 2026.
  • Merrithew & Thorsten Inc left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Merrithew & Thorsten Inc's portfolio in Q2 2026, its #84 holding.
  • Merrithew & Thorsten Inc first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Merrithew & Thorsten Inc's Gilead Sciences position peaked at $7K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Merrithew & Thorsten Inc's 13F filing for Q2 2026, filed 31 Jul 2026.